首页> 美国卫生研究院文献>PLoS Clinical Trials >Hepatitis B and C Co-Infection among HIV-Infected Adults while on Antiretroviral Treatment: Long-Term Survival, CD4 Cell Count Recovery and Antiretroviral Toxicity in Cambodia

【2h】

Hepatitis B and C Co-Infection among HIV-Infected Adults while on Antiretroviral Treatment: Long-Term Survival, CD4 Cell Count Recovery and Antiretroviral Toxicity in Cambodia

机译：在接受抗逆转录病毒治疗的艾滋病毒感染成年人中，乙型和丙型肝炎合并感染：柬埔寨的长期存活，CD4细胞计数恢复和抗逆转录病毒毒性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundDespite the high burden, there is a dearth of (long-term) outcome data of hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infected patients receiving antiretroviral treatment (ART) in a clinical setting in resource-constrained settings, particularly from Asia.

机译：背景尽管负担沉重，但在资源有限的临床环境中，接受抗逆转录病毒治疗（ART）的乙肝病毒（HBV）和丙肝病毒（HCV）合并感染患者的（长期）结局数据缺乏，尤其是来自亚洲的。

著录项

期刊名称 PLoS Clinical Trials
作者
Johan van Griensven; Lay Phirum; Kimcheng Choun; Sopheak Thai; Anja De Weggheleire; Lutgarde Lynen;
展开▼
作者单位

展开▼
年(卷),期 2010(9),2
年度 2010
页码 e88552
总页数 9
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Risk Factors for Low CD4(+) Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4(+) Counts > 500 Cells/mm(3): Findings From the Strategic Timing of AntiRetroviral Therapy (START) Trial [J] . Boatman Jeffrey A., Baker Jason V., Emery Sean, JAIDS: Journal of acquired immune deficiency syndromes . 2019,第1期

机译：低CD4（+）计数恢复的危险因素尽管参与者在抗逆转录病毒治疗和CD4（+）计数> 500细胞/ mm（3）中的病毒抑制：来自抗逆转录病毒治疗（开始）试验的战略时机的调查结果
2. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. [J] . Lewden C, Chene G, Morlat P, JAIDS: Journal of acquired immune deficiency syndromes . 2007,第1期

机译：长期联合抗逆转录病毒疗法的CD4细胞计数大于500个细胞/ mm3的HIV感染成年人的死亡率与普通人群相同。
3. Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count. [J] . Chamie G, Charlebois ED, Srikantiah P, Clinical infectious diseases . 2010,第3期

机译：在具有高CD4（+）细胞计数的HIV感染的成年人中，即刻与CD4（+）启动的抗逆转录病毒疗法的随机试验中，结核分枝杆菌的微生物学和临床治疗结果。
4. Analysis of Treatment for HIV-infected Patients Considering CD4 T Cell Count in STI [C] . Ki Yeon Park, Han Byul Chung, Chung Choo Chung SICE-ICASE International Joint Conference . 2006

机译：考虑STI CD4 T细胞计数的艾滋病毒感染患者治疗分析
5. CD4+ T Cell Recovery and Cerebrospinal Fluid Escape After Antiretroviral Therapy Initiation in Acute HIV-1 Infection [D] . ?Handoko, Ryan Christopher 2020

机译：CD4 + T 细胞回收和急性 HIV-1 感染脑脊液逃逸抗逆转录病毒疗法开始后
6. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART) study in South Africa [O] . P Bock, K Nel, G Fatti, -1

机译：在HIV预防试验网络071中无论基线CD4计数是多少开始抗逆转录病毒治疗的成年人中基线CD4细胞计数导致的肾功能不全HPTN 071;抗逆转录病毒疗法对减少HIV传播的人口效应PopART研究在南非
7. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia. [O] . Johan van Griensven, Lay Phirum, Kimcheng Choun, 2014

机译：抗逆转录病毒治疗期间感染艾滋病毒的成人中的乙型肝炎和丙型肝炎共感染：柬埔寨的CD4细胞计数恢复和抗逆转录病毒毒性。
8. Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS [R] . Marconi, V. C., Grandits, G., Okulicz, J. F., 2011

机译：艾滋病病毒感染者抗逆转录病毒治疗后的累积病毒载量和病毒学衰变模式影响CD4恢复和艾滋病

Hepatitis B and C Co-Infection among HIV-Infected Adults while on Antiretroviral Treatment: Long-Term Survival, CD4 Cell Count Recovery and Antiretroviral Toxicity in Cambodia

摘要

著录项

相似文献

相关主题

期刊订阅